Through chemotherapy and a stem cell transplant, Gregory Proctor survived multiple myeloma.

In this powerful interview on CancerInterviews.com, we share the remarkable story of Gregory Proctor, who battled and survived multiple myeloma, a rare and aggressive form of blood cancer that attacks plasma cells in the bone marrow and often causes painful bone lesions. Gregory's journey began in the spring of 2011 with persistent lower back pain. Within a month, the pain became so severe that he could barely move. After a series of diagnostic tests, including a non-contrast MRI, Gregory underwent a more conclusive contrast MRI—which lit up "like a Christmas tree," revealing cancer spread throughout his lower extremities. A subsequent bone marrow biopsy—which he describes as the most painful experience of his life—confirmed the diagnosis: Multiple Myeloma IGA Kappa P-17, a high-risk form of the disease. Gregory’s treatment plan involved a powerful combination of Darzalex, Velcade (vercade), and Dexamethasone, a five-day-a-week chemotherapy regimen designed to aggressively target the cancer. These drugs played distinct roles: Darzalex (daratumumab): A monoclonal antibody targeting myeloma cells Velcade (bortezomib): A proteasome inhibitor that disrupts cancer cell growth Dexamethasone: A corticosteroid that helped control inflammation and appetite, which was vital to keep Gregory strong enough for the next step—a stem cell transplant In October 2021, Gregory achieved remission. By February, he was ready for the critical next phase: a stem cell transplant. Before the transplant, he received a high dose of Melphalan, a chemotherapy agent that completely wiped out his immune system to prepare his body to accept the stem cells. Four million stem cells were reintroduced into his bloodstream, aiming to engraft in his bone marrow. However, this phase was not without complications. Gregory developed Engraftment Syndrome, leading to fever, nausea, diarrhea, and extreme fatigue. His 21-day hospital stay was grueling, but his determination never wavered. Once discharged, recovery was slow and difficult. He described the early weeks as shuttling between bed and couch, but by May, his energy started to return. Today, Gregory continues maintenance chemotherapy twice a month, and while he estimates he's at 90% of his former health, he acknowledges the toll the cancer and treatment took—physically, mentally, and emotionally. Gregory offers this advice to others facing a cancer diagnosis: “Never give up. The moment you let doubt, fear, or insecurity in, the fight becomes that much harder. Enjoy every day and never take life for granted.” KEY TOPICS & TREATMENTS COVERED: Multiple Myeloma diagnosis & symptoms Bone lesions and back pain Bone marrow biopsy experience Chemotherapy regimen: Darzalex, Velcade, Dexamethasone Stem Cell Transplant procedure Use of Melphalan Engraftment Syndrome Recovery and remission timeline Mental and physical toll of cancer Survivorship and mindset Cancer support groups and resources ADDITIONAL RESOURCES: Gregory’s podcast: www.k2tcpodcast.com Leukemia & Lymphoma Society Support: www.lls.org Interview by Bruce Morton | Visit CancerInterviews.com for more survivor stories and expert advice on navigating life after a cancer diagnosis. TAGS: #MultipleMyeloma #StemCellTransplant #BoneMarrowBiopsy #Darzalex #Velcade #Dexamethasone #GregoryProctor #CancerSurvivor #Chemotherapy #Melphalan #EngraftmentSyndrome #CancerInterviews #BoneLesions #BruceMorton If this story inspired you, please Like, Comment, and Subscribe for more real-life stories from cancer warriors.